Search Within

Elisa De Stanchina

  1. "Ouathek Ouerfelli"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (1)
Groups
  1. Sloan Kettering Institute Postdocs (9)
  2. Department of Medicine (8)
  3. GSK Faculty (8)
  4. Human Oncology and Pathogenesis Program (7)
  5. Center for Hematologic Malignancies (6)
  6. Executive Committee, Center for Hematologic Malignancies (5)

More Groups

People
  1. Ouathek Ouerfelli (10)
  2. Hakim Djaballah (3)
  3. Inna Khodos (3)
  4. Alan Chramiec (2)
  5. Anas Younes (2)
  6. Andrei Krivtsov (2)

More People

Years
  1. 2025 (1)
  2. 2021 (2)
  3. 2018 (1)
  4. 2016 (3)
  5. 2015 (1)
  6. 2012 (1)

More Years

Publications
  1. Cancer Research (3)
  2. Nature Medicine (2)
  3. Blood (1)
  4. Cell Reports (1)
  5. Clinical Cancer Research (1)
  6. Journal of Clinical Investigation (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. Nature Publishing Group (2)
  3. American Society for Clinical Investigation (1)
  4. American Society of Hematology (1)
  5. Cell Press (1)
  6. National Academy of Sciences (1)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer
    Journal Article

    Boyer, J. A.; Rosen, E. Y.; Sharma, M.; Dorso, M. A.; Mai, N.; Amor, C.; Reiter, J. M.; Kannan, R.; Gadal, S.; Xu, J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2025)

    Fulltext@MSK | Save
  • Targeting germline- and tumor-associated nucleotide excision repair defects in cancer
    Journal Article

    Topka, S.; Steinsnyder, Z.; Ravichandran, V.; Tkachuk, K.; Kemel, Y.; Bandlamudi, C.; Madsen, M. W.; Furberg, H.; Ouerfelli, O.; Rudin, C. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Targeting eIF4A-dependent translation of KRAS signaling molecules
    Journal Article

    Singh, K.; Lin, J.; Lecomte, N.; Mohan, P.; Gokce, A.; Sanghvi, V. R.; Jiang, M.; Grbovic-Huezo, O.; Burčul, A.; Stark, S. G.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • BET inhibition-induced GSK3β feedback enhances lymphoma vulnerability to PI3K inhibitors
    Journal Article

    Derenzini, E.; Mondello, P.; Erazo, T.; Portelinha, A.; Liu, Y.; Scallion, M.; Asgari, Z.; Philip, J.; Hilden, P.; Valli, D.; more...
    Cell Reports (2018)

    Fulltext@MSK | Save
  • MYC-dependent PI3K and MCL-1 feedbacks attenuate BET inhibitors activity in diffuse large B-cell lymphoma
    Meeting Abstract

    Derenzini, E.; Mondello, P.; Liu, Y.; Scallion, M.; Asgari, Z.; Philip, J.; Hilden, P.; Djaballah, H.; Ouerfelli, O.; de Stanchina, E.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Proteasome addiction defined in Ewing sarcoma is effectively targeted by a novel class of 19S proteasome inhibitors
    Journal Article

    Shukla, N.; Somwar, R.; Smith, R. S.; Ambati, S.; Munoz, S.; Merchant, M.; D'Arcy, P.; Wang, X.; Kobos, R.; Antczak, C.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status"
    Journal Article

    LaFave, L. M.; Béguelin, W.; Koche, R.; Teater, M.; Spitzer, B.; Chramiec, A.; Papalexi, E.; Keller, M. D.; Hricik, T.; Konstantinoff, K.; more...
    Nature Medicine (2016)

    Fulltext@MSK | Save
  • Loss of BAP1 function leads to EZH2-dependent transformation
    Journal Article

    LaFave, L. M.; Béguelin, W.; Koche, R.; Teater, M.; Spitzer, B.; Chramiec, A.; Papalexi, E.; Keller, M. D.; Hricik, T.; Konstantinoff, K.; more...
    Nature Medicine (2015)

    Fulltext@MSK | Save
  • ARN-509: A novel antiandrogen for prostate cancer treatment
    Journal Article

    Clegg, N. J.; Wongvipat, J.; Joseph, J. D.; Tran, C.; Ouk, S.; Dilhas, A.; Chen, Y.; Grillot, K.; Bischoff, E. D.; Cai, L.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer
    Journal Article

    Regales, L.; Gong, Y.; Shen, R.; de Stanchina, E.; Vivanco, I.; Goel, A.; Koutcher, J. A.; Spassova, M.; Ouerfelli, O.; Mellinghoff, I. K.; more...
    Journal of Clinical Investigation (2009)

    Fulltext@MSK | Save